Concert Pharmaceuticals, Inc. Deferred Revenue Recognized
Concert Pharmaceuticals, Inc. reported Deferred Revenue Recognized of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2020-02-27
- Concert Pharmaceuticals, Inc. contract with customer, liability, revenue recognized for the quarter ending 2018-09-30 was $0.00.
- Concert Pharmaceuticals, Inc. contract with customer, liability, revenue recognized for the quarter ending 2018-06-30 was $0.00.
- Concert Pharmaceuticals, Inc. contract with customer, liability, revenue recognized for the quarter ending 2018-03-31 was $16.00K.
- Concert Pharmaceuticals, Inc. contract with customer, liability, revenue recognized for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Concert Pharmaceuticals, Inc. contract with customer, liability, revenue recognized for fiscal 2018 was $16.00K.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 | |||
| 2018-12-31 | $16.00K 10-K · filed 2020-02-27 | |||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 | $16.00K 10-Q · filed 2018-11-01 | ||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-02 | $16.00K 10-Q · filed 2018-08-02 | ||
| 2018-03-31 | $16.00K 10-Q · filed 2018-05-03 |